Vitiligo is a chronic skin condition in which patches of skin lose their color, turning white or very light compared to surrounding areas. It affects roughly 0.4% of the global population, can appear at any age, and occurs across all skin tones, though the contrast is more visible on darker skin. The color loss happens because the immune system attacks and destroys melanocytes, the cells responsible for producing skin pigment.
Why Melanocytes Are Destroyed
Vitiligo is fundamentally an autoimmune condition. The process starts with oxidative stress, a buildup of harmful molecules called reactive oxygen species inside melanocytes. These molecules damage the cells’ DNA, proteins, and internal structures, particularly the mitochondria (the cell’s energy source) and the endoplasmic reticulum (a structure involved in protein processing). This damage weakens the melanocytes and, critically, makes them visible to the immune system by pushing certain proteins to the cell surface that act like distress signals.
Once the immune system detects these stressed melanocytes, it responds aggressively. A specific type of immune cell, CD8+ T cells, carries out the actual killing. The immune response is further amplified by an imbalance: the body’s pro-inflammatory responses are ramped up while the regulatory cells that normally keep the immune system in check are underperforming. This creates a cycle where melanocytes are progressively destroyed and the immune system stays on alert for more.
Oxidative stress also weakens the physical bond between melanocytes and the surrounding skin cells, causing some melanocytes to simply detach from the skin before they’re even killed by the immune system.
Genetic and Autoimmune Links
About 50 different genetic regions have been identified that contribute to vitiligo risk. Many of these same genes are involved in other autoimmune conditions, which explains why vitiligo frequently appears alongside them. The strongest genetic association is with a specific immune system gene called HLA-DR4, which also plays a role in several other autoimmune diseases.
Autoimmune thyroid disease is the most common companion condition. Depending on the study, anywhere from 3% to 32% of people with vitiligo also have a thyroid disorder, most often hypothyroidism or autoimmune thyroiditis. The connection is strong enough that many dermatologists will check thyroid function as part of a vitiligo evaluation. Other conditions that show up more frequently in people with vitiligo include pernicious anemia, Addison’s disease, lupus, rheumatoid arthritis, type 1 diabetes, and psoriasis.
Two Main Types
Vitiligo is broadly divided into non-segmental and segmental forms, and the distinction matters because they behave very differently over time.
Non-segmental vitiligo is the more common type. Patches typically appear symmetrically on both sides of the body, often on the hands, face, and areas around body openings. It’s the more unpredictable form: reactivation occurs in 80% to 100% of patients regardless of how long the disease has been stable. There’s no duration of stability after which flare-ups become unlikely.
Segmental vitiligo tends to affect one side or one segment of the body. It usually stabilizes faster and behaves more predictably. After two years of stability, the odds of reactivation drop significantly. Patients with more than two years of stable segmental vitiligo are about one-fifth as likely to experience a flare compared to those with less than two years of stability.
How Vitiligo Is Diagnosed
Diagnosis is usually clinical, meaning a dermatologist can often identify vitiligo by looking at the skin. A Wood’s lamp, which emits ultraviolet light, is a common tool used during the exam. Under this light, areas that have lost their melanocytes glow bright white, making patches easier to see, especially on lighter skin where the contrast may not be obvious in normal lighting. This also helps distinguish vitiligo from other conditions that cause lighter patches, such as fungal infections or post-inflammatory changes, which look different under UV light.
Treatment Options
Light Therapy
Narrowband UVB phototherapy is one of the most established treatments, particularly for widespread vitiligo. Sessions are typically scheduled twice a week on non-consecutive days. The response can be surprisingly quick: initial signs of repigmentation appear as early as the second or third week, with the average patient seeing the first specks of returning color around three weeks in. Full results take much longer, often requiring months of consistent sessions.
Topical Treatments
Ruxolitinib cream, a topical JAK inhibitor, became the first FDA-approved treatment specifically for vitiligo repigmentation. In pooled data from two large clinical trials, about 50% of patients who applied the cream for a full year achieved at least 75% repigmentation on their face. Patients who started treatment later (after 24 weeks on a placebo) still saw meaningful results, with roughly 30% reaching that same threshold in just 28 weeks of active use. These results held across different ages, skin types, and disease characteristics. Topical corticosteroids and calcineurin inhibitors are also commonly used, particularly for smaller or more localized patches.
Surgical Approaches
Surgery is an option for people whose vitiligo has been stable, meaning no new patches and no growth of existing ones, for at least one year. The basic concept involves transplanting melanocytes from unaffected skin to depigmented areas. Techniques range from mini-punch grafting and suction blister grafting (where tiny sections of skin or just the top layer are moved) to more advanced cellular methods where melanocytes are separated from a skin sample and applied as a suspension to the affected area. Surgery tends to work best for segmental vitiligo and for well-defined, stable patches that haven’t responded to other treatments.
Cosmetic Camouflage
Many people with vitiligo use cosmetic products to even out their skin tone, either as a standalone approach or while waiting for treatments to take effect. The options range from quick daily solutions to longer-lasting methods.
- Cream and liquid camouflage: Applied with clean fingertips and set with loose powder. These need to be removed and reapplied daily for hygiene, but a theatrical fixing spray can extend their wear time significantly.
- Self-tanners: Last four to six days per application and won’t rub off on clothing, making them lower-maintenance than daily makeup. They can be applied manually or with an airbrush.
- Skin-staining pens: Water-based pens designed for small areas like fingertips, lips, or eyebrows. The color doesn’t transfer to clothing and works well for precise, detailed coverage.
- Medical tattooing: Semi-permanent inks are tattooed into depigmented skin, matching the surrounding tone. Results last up to about a year before touch-ups are needed. This works best for stable patches in areas that don’t change color much with sun exposure.
Airbrush foundation products, which set matte almost on contact with the skin, offer another option. They can be applied with a sponge or fingers without needing the actual airbrush equipment, and silicone-based versions allow slightly more working time before they dry.
What Affects How Vitiligo Progresses
Vitiligo is unpredictable. Some people develop a single small patch that never grows. Others experience gradual spread over years or decades. Stress, skin trauma (including sunburn), and hormonal changes are commonly reported triggers for new patches, though the relationship isn’t fully understood. The face, hands, wrists, and areas around the eyes, mouth, and groin are the most commonly affected sites, likely because these areas experience more friction and sun exposure.
The segmental type generally follows a more contained course, often stabilizing within a couple of years and staying put. Non-segmental vitiligo is the less predictable form, with flare-ups possible even after years of quiet. This distinction shapes treatment planning: segmental vitiligo that stabilizes becomes a good candidate for surgical correction, while non-segmental vitiligo often requires longer-term medical management to control activity and encourage repigmentation.